The invention provides a chimeric antigen receptor (CAR) which can specifically bind to a BCMA protein) comprising a BCMA binding structural domain, a transmembrane domain, a co-stimulatory domain, and an intracellular signaling domain. The invention also provides uses of the CAR in treating diseases or conditions linked to the expression of BCMA.